medigraphic.com
SPANISH

Salud Jalisco

ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 3

<< Back Next >>

Sal Jal 2024; 11 (3)

Renal disease in Mexican patients as an aggravating factor in COVID-19 lethality

Fonseca-León J, Ramos-Herrera IM
Full text How to cite this article 10.35366/115744

DOI

DOI: 10.35366/115744
URL: https://dx.doi.org/10.35366/115744

Language: Spanish
References: 5
Page: 124-127
PDF size: 248.08 Kb.


Key words:

COVID-19, kidney disease, lethality, comorbidity.

ABSTRACT

Patients with kidney disease prior to COVID-19 infection can lead to complications that are most likely to result in death, as they present with kidney-inducing symptomatology during the course of infection. However, patients who have never had kidney disease may begin to develop kidney problems after COVID-19 infection. The list of cases over two years (February 2020-February 2022) shows that 1.11% of cases with COVID-19 have pre-existing kidney disease, with a case fatality rate of 38.04% of cases. A predisposition to die in patients with COVID-19 with renal disease was found especially in older patients (50.0% in those over 70 years of age), and the predisposition increases when conditions such as arterial hypertension, diabetes mellitus or heart disease are added.


REFERENCES

  1. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-218. doi: 10.1016/j.kint.2020.05.006.

  2. Félix-Mendoza AG, Flores-Parada GV, González-González FJ, Picos-Contreras JA, Campa-Navarro AB. Afecciones renales por COVID-19: revisión sistemática. REMUS. 2021;(6):20-28.

  3. Zayas-Fundora E. Impacto desfavorable de la COVID-19 sobre el riñón. Spimed, 2020;1(3):29.

  4. Secretaría de Salud. Datos Abiertos Bases Históricas. Dirección General de Epidemiología. https://www.gob.mx/salud/documentos/datos-abiertos-bases-historicas-direccion-general- de-epidemiologia.

  5. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308-310.




Figure 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Sal Jal. 2024;11